AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Qualigen Therapeutics, Inc. Director's Dealing 2016

Nov 15, 2016

35251_dirs_2016-11-15_32c02094-c80e-4506-bd26-739b185ac3ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2015-06-24

Reporting Person: Doyle Noah (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22727	Direct

Footnotes

F1: These shares were inadvertently omitted from the reporting person's original Form 3, and were also omitted from two Form 4s filed by the reporting person after his original Form 3 was filed.